Medis Revenue Growth
Strong and stable financial performance enables Medis to present a low level of risk to its business partners. Over the past five years, Medis has seen average revenue increases of nearly 16 percent per year, ending the 2020 fiscal year with revenues of €136.1 million, up 11.9 percent year-over-year.
Medis meets Dun & Bradstreet's highest financial credit rating criteria every year. Medis's Dun & Bradstreet rating is 4A1.
Platinum Excellence Award
For 2020, we have been officially recognized as one of Slovenia’s most reliable companies entitled to use the internationally recognized status of Platinum Excellence, a symbol of truly exceptional credit. This achievement is the result of an excellent team, state-of-the-art technology, and the desire to be better. We thank our partners, clients, and patients for placing their trust in us and recognizing us as a reliable partner in providing the region’s best possible medical solutions.
Medis is a reliable and credible business partner with a low risk level. The right level of business diversification, development strategy, and modern and accurate financial planning translates to financial strength. It is critical to balance development and long-term risk. Erna Slana Chief Finance Officer
What our partners say about us
They have built a team with rhythm with collaboration at the very heart of everything they do. It’s a pleasure to work with such a great group of individuals who really understand what we do."
Marketing Lead MS IPM
Director, Strategic Business Partnerships Management (EMEA)
Director Sales Europe Third Party, Hospital Care Division
Regional Head of the Central/Eastern Europe and the CIS at Besins Healthcare, Russian Federation
Head of Established Brands, International Markets
I think we were growing scientifically together, because your colleagues were always coming back to us with difficult questions regarding product, substances, compositions, applications, that really helped us. Thirdly because of your great employees that are dedicated to our brand. We only wish to have partners like Medis in other countries! So wherever Medis is going in the future – you can count on us as well."
Founder of Pleuran
With Medis we have a long term partnership, a tradition and we respect that. Also it is great that one company has affiliates in different countries, so this model is most optimal for further collaboration for our Gengigel products."
Founder and President of company Ricerfarma